Semi-Annual Consolidated Balance Sheet

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7310818

Concept As at
2024-06-30
As at
2023-12-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
5,152,000,000 JPY
5,484,000,000 JPY
Other
217,000,000 JPY
264,000,000 JPY
Current assets
8,795,000,000 JPY
9,109,000,000 JPY
Non-current assets
Property, plant and equipment
3,494,000,000 JPY
3,581,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
983,000,000 JPY
1,025,000,000 JPY
Machinery, equipment and vehicles
Machinery, equipment and vehicles, net
758,000,000 JPY
826,000,000 JPY
Land
1,675,000,000 JPY
1,675,000,000 JPY
Construction in progress
22,000,000 JPY
2,000,000 JPY
Other
Other, net
53,000,000 JPY
50,000,000 JPY
Intangible assets
Intangible assets
24,000,000 JPY
1,000,000 JPY
Investments and other assets
1,068,000,000 JPY
527,000,000 JPY
Investments and other assets
Investment securities
781,000,000 JPY
236,000,000 JPY
Other
286,000,000 JPY
291,000,000 JPY
Non-current assets
4,587,000,000 JPY
4,111,000,000 JPY
Assets
13,383,000,000 JPY
13,220,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
380,000,000 JPY
375,000,000 JPY
Income taxes payable
39,000,000 JPY
42,000,000 JPY
Asset retirement obligations
17,000,000 JPY
203,000,000 JPY
Other
264,000,000 JPY
281,000,000 JPY
Current liabilities
2,437,000,000 JPY
3,046,000,000 JPY
Non-current liabilities
Long-term borrowings
1,326,000,000 JPY
1,999,000,000 JPY
Retirement benefit liability
620,000,000 JPY
624,000,000 JPY
Asset retirement obligations
20,000,000 JPY
20,000,000 JPY
Other
333,000,000 JPY
210,000,000 JPY
Non-current liabilities
2,871,000,000 JPY
3,433,000,000 JPY
Liabilities
5,308,000,000 JPY
6,480,000,000 JPY
Provision for bonuses
48,000,000 JPY
75,000,000 JPY
Net assets
Shareholders' equity
Share capital
10,000,000 JPY
2,267,000,000 JPY
Capital surplus
4,997,000,000 JPY
2,689,000,000 JPY
Retained earnings
2,393,000,000 JPY
1,628,000,000 JPY
Treasury shares
-273,000,000 JPY
-300,000,000 JPY
Shareholders' equity
7,126,000,000 JPY
6,284,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
469,000,000 JPY
91,000,000 JPY
Foreign currency translation adjustment
477,000,000 JPY
363,000,000 JPY
Valuation and translation adjustments
947,000,000 JPY
454,000,000 JPY
Share acquisition rights
JPY
0 JPY
Net assets
8,074,000,000 JPY
6,739,000,000 JPY
Liabilities and net assets
13,383,000,000 JPY
13,220,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.